References
- Hofny, H. A.; Mohamed, M. F. A.; Gomaa, H. A. M.; Abdel-Aziz, S. A.; Youssif, B. G. M.; El-Koussi, N. A.; Aboraia, A. S. Design, Synthesis, and Antibacterial Evaluation of New Quinoline-1,3,4-Oxadiazole and Quinoline-1,2,4-Triazole Hybrids as Potential Inhibitors of DNA Gyrase and Topoisomerase IV. Bioorg. Chem. 2021, 112, 104920–104912. DOI: https://doi.org/10.1016/j.bioorg.2021.104920.
- Jansen, K. U.; Knirsch, C.; Anderson, A. S. The Role of Vaccines in Preventing Bacterial Antimicrobial Resistance. Nat. Med. 2018, 24, 10–20. DOI: https://doi.org/10.1038/nm.4465.
- Khalilullah, H.; Khan, S.; Nomani, M. S.; Ahmed, B. Synthesis, Characterization and Antimicrobial Activity of Benzodioxane Ring Containing 1,3,4-Oxadiazole Derivatives. Arab. J. Chem. 2016, 9, 1029–1035. DOI: https://doi.org/http://dx.doi.org/10.1016/j.arabjc.2011.11.009.
- Hannoun, M. H.; Hagras, M.; Kotb, A.; El-Attar, A. M. M.; Abulkhair, H. S. Synthesis and Antibacterial Evaluation of a Novel Library of 2-(Thiazol-5-yl)-1,3,4-Oxadiazole Derivatives against Methicillin-Resistant Staphylococcus aureus (MRSA). Bioorg. Chem. 2020, 94, 103364–103310. DOI: https://doi.org/10.1016/j.bioorg.2019.103364.
- Li, Y.; Luo, Y.; Hu, Y.; Zhu, D. D.; Zhang, S.; Liu, Z. J.; Gong, H. B.; Zhu, H. L. Design, Synthesis and Antimicrobial Activities of Nitroimidazole Derivatives Containing 1,3,4-Oxadiazole Scaffold as FabH Inhibitors. Bioorg. Med. Chem. 2012, 20, 4316–4322. DOI: https://doi.org/10.1016/j.bmc.2012.05.050.
- Nayak, S.; Sinha, R. K.; Lewis, P. M.; Kulkarni, S. D.; Gaonkar, S. L. Synthesis, Characterization, DFT and Photophysical Studies of New Class of 1,3,4-Oxadiazole-Isobenzofuran Hybrids. J. Lumin. 2021, 238, 118212–118219. DOI: https://doi.org/10.1016/j.jlumin.2021.118212.
- Singh, R. B.; Das, N.; Singh, G. K.; Singh, S. K.; Zaman, K. Synthesis and Pharmacological Evaluation of 3-[5-(Aryl-[1,3,4]Oxadiazole-2-yl]-Piperidine Derivatives as Anticonvulsant and Antidepressant Agents. Arab. J. Chem. 2020, 13, 5299–5311. DOI: https://doi.org/10.1016/j.arabjc.2020.03.009.
- Karabelyov, V.; Kondeva-Burdina, M.; Angelova, V. T. Synthetic Approaches to Unsymmetrical 2,5-Disubstituted 1,3,4-Oxadiazoles and Their MAO-B Inhibitory Activity. A Review. Bioorg. Med. Chem. 2021, 29, 115888–115822. DOI: https://doi.org/10.1016/j.bmc.2020.115888.
- Acar Çevik, U.; Sağlık, B. N.; Osmaniye, D.; Levent, S.; Kaya Çavuşoğlu, B.; Karaduman, A. B.; Atlıd, Ö.; Atlı Eklioğlu, Ö.; Kaplancıklı, Z. A. Synthesis, Anticancer Evaluation and Molecular Docking Studies of New Benzimidazole- 1,3,4-Oxadiazole Derivatives as Human Topoisomerase Types I Poison. J. Enzyme Inhib. Med. Chem. 2020, 35, 1657–1673. DOI: https://doi.org/10.1080/14756366.2020.1806831.
- Duhan, M.; Kumar, P.; Sindhu, J.; Singh, R.; Devi, M.; Kumar, A.; Kumar, R.; Lal, S. Exploring Biological Efficacy of Novel Benzothiazole Linked 2,5-Disubstituted-1,3,4-Oxadiazole Hybrids as Efficient α-Amylase Inhibitors: Synthesis, Characterization, Inhibition, Molecular Docking, Molecular Dynamics and Monte Carlo Based QSAR Studies. Comput. Biol. Med. 2021, 138, 104876–104818. DOI: https://doi.org/10.1016/j.compbiomed.2021.104876.
- Ningaiah, S.; Bhadraiah, U. K.; Doddaramappa, S. D.; Keshavamurthy, S.; Javarasetty, C. Novel Pyrazole Integrated 1,3,4-Oxadiazoles: Synthesis, Characterization and Antimicrobial Evaluation. Bioorg. Med. Chem. Lett. 2014, 24, 245–248. DOI: https://doi.org/10.1016/j.bmcl.2013.11.029.
- Bitla, S.; Sagurthi, S. R.; Dhanavath, R.; Puchakayala, M. R.; Birudaraju, S.; Gayatri, A. A.; Bhukya, V. K.; Atcha, K. R. Design and Synthesis of Triazole Conjugated Novel 2,5-Diaryl Substituted 1,3,4 Oxadiazoles as Potential Antimicrobial and Antifungal Agents. J. Mol. Struct. 2020, 1220, 128705–128713. DOI: https://doi.org/10.1016/j.molstruc.2020.128705.
- Nayak, S.; Gaonkar, S. L.; Musad, E. A.; Dawsar, A. M. A. 1,3,4-Oxadiazole-Containing Hybrids as Potential Anticancer Agents: Recent Developments, Mechanism of Action and Structure-Activity Relationships. J. Saudi Chem. Soc. 2021, 25, 101284–101229. DOI: https://doi.org/10.1016/j.jscs.2021.101284.
- Desai, N. C.; Bhatt, N.; Somani, H.; Trivedi, A. Synthesis, Antimicrobial and Cytotoxic Activities of Some Novel Thiazole Clubbed 1,3,4-Oxadiazoles. Eur. J. Med. Chem. 2013, 67, 54–59. DOI: https://doi.org/10.1016/j.ejmech.2013.06.029.
- Wang, X.; Hu, H.; Zhao, X.; Chen, M.; Zhang, T.; Geng, C.; Mei, Y.; Lu, A.; Yang, C. Novel Quinazolin-4(3H)-One Derivatives Containing a 1,3,4-Oxadiazole Thioether Moiety as Potential Bactericides and Fungicides: Design, Synthesis, Characterization and 3D-QSAR Analysis. J. Saudi Chem. Soc. 2019, 23, 1144–1156. DOI: https://doi.org/10.1016/j.jscs.2019.07.006.
- Kandemir, H.; Ma, C.; Kutty, S. K.; Black, D.; Griffith, R.; Lewis, P. J.; Kumar, N. Synthesis and Biological Evaluation of 2,5-di(7-Indolyl)-1,3,4-Oxadiazoles, and 2- and 7-Indolyl 2-(1,3,4-Thiadiazolyl)Ketones as Antimicrobials. Bioorg. Med. Chem. 2014, 22, 1672–1679. DOI: https://doi.org/10.1016/j.bmc.2014.01.025.
- Ningegowda, R.; Chandrashekharappa, S.; Singh, V.; Mohanlall, V.; Venugopala, K. N. Design, Synthesis and Characterization of Novel 2-(2,3-Dichlorophenyl)-5-Aryl-1,3,4-Oxadiazole Derivatives for Their anti-Tubercular Activity against Mycobacterium tuberculosis. Chem. Data Collect. 2020, 28, 100431–100438. DOI: https://doi.org/10.1016/j.cdc.2020.100431.
- Farshori, N. N.; Rauf, A.; Siddiqui, M. A.; Al-Sheddi, E. S.; Al-Oqail, M. M. A Facile One-Pot Synthesis of Novel 2,5-Disubstituted-1,3,4-Oxadiazoles under Conventional and Microwave Conditions and Evaluation of Their in Vitro Antimicrobial Activities. Arab. J. Chem. 2017, 10, 2853–2861. DOI: https://doi.org/http://dx.doi.org/10.1016/j.arabjc.2013.11.010.
- Shi, J.; Luo, N.; Ding, M.; Bao, X. Synthesis, in Vitro Antibacterial and Antifungal Evaluation of Novel 1,3,4-Oxadiazole Thioether Derivatives Bearing the 6-Fluoroquinazolinylpiperidinyl Moiety. Chinese Chem. Lett. 2020, 31, 434–438. DOI: https://doi.org/10.1016/j.cclet.2019.06.037.
- Tresse, C.; Radigue, R.; Borowski, R. G. V.; Thepaut, M.; Le, H. H.; Demay, F.; Georgeault, S.; Dhalluin, A.; Trautwetter, A.; Ermel, G.; et al. Synthesis and Evaluation of 1,3,4-Oxadiazole Derivatives for Development as Broad-Spectrum Antibiotics. Bioorg. Med. Chem. 2019, 27, 115097–115097. DOI: https://doi.org/10.1016/j.bmc.2019.115097.
- Alumasa, J. N.; Keiler, K. C. Clicking on Trans-Translation Drug Targets. Front. Microbiol. 2015, 6, 498–494. DOI: https://doi.org/10.3389/fmicb.2015.00498.
- Keiler, K. C.; Feaga, H. A. Resolving Nonstop Translation Complexes is a Matter of Life or Death. J. Bacteriol. 2014, 196, 2123–2130. DOI: https://doi.org/10.1128/JB.01490-14.
- Ramadoss, N. S.; Alumasa, J. N.; Cheng, L.; Wang, Y.; Li, S.; Chambers, B. S.; Chang, H.; Chatterjee, A. K.; Brinker, A.; Engels, I. H.; Keiler, K. C. Small Molecule Inhibitors of Trans-Translation Have Broad-Spectrum Antibiotic Activity. Proc. Natl. Acad. Sci. USA. 2013, 110, 10282–10287. DOI: https://doi.org/10.1073/pnas.1302816110.
- Song, X.; Li, P.; Li, M.; Yang, A.; Yu, L.; Luo, L.; Hu, D.; Song, B. Synthesis and Investigation of the Antibacterial Activity and Action Mechanism of 1,3,4-Oxadiazole Thioether Derivatives. Pestic. Biochem. Phys. 2018, 147, 11–19. DOI: https://doi.org/10.1016/j.pestbp.2017.10.011.
- Labovská, S. Pseudomonas aeruginosa as a cause of nosocomial infections. Pseudomonas aeruginosa-biofilm formation, infections and treatments, IntechOpen 2021, 75039. DOI: https://doi.org/10.5772/intechopen.95908.
- Dong, J.; Wang, N. N.; Yao, Z. J.; Zhang, L.; Cheng, Y.; Ouyang, D.; Lu, A. P.; Cao, D. S. ADMETlab: A Platform for Systematic ADMET Evaluation Based on a Comprehensively Collected ADMET Database. J. Chem. Inform. 2018, 10, 1–11. DOI: https://doi.org/10.1186/s13321-018-0283-x.
- Sultan, M. A.; Galil, M. S. A.; Al-Qubati, M.; Omar, M. M.; Barakat, A. Synthesis, Molecular Docking, Druglikeness Analysis, and ADMET Prediction of the Chlorinated Ethanoanthracene Derivatives as Possible Antidepressant Agents. Appl. Sci. 2020, 10, 7727–7719. DOI: https://doi.org/10.3390/app10217727.
- Schyman, P.; Liu, R.; Desai, V.; Wallqvist, A. vNN Web Server for ADMET Predictions. Front. Pharmacol. 2017, 8, 889–814. DOI: https://doi.org/10.3389/fphar.2017.00889.
- Rashid, M.; Afzal, O.; Altamimi, A. S. A. Benzimidazole Molecule Hybrid with Oxadiazole Ring as Antiproliferative Agents: In-Silico Analysis, Synthesis and Biological Evaluation. J. Chil. Chem. Soc. 2021, 66, 5164–5182. DOI: https://doi.org/10.4067/S0717-97072021000205164.
- Kocyigit-Kaymakcioglu, B.; Yazici, S. S.; Tok, F.; Dikmen, M.; Engür, S.; Oruc-Emre, E. E.; Iyidogan, A. Synthesis and Anticancer Activity of New Hydrazide-Hydrazones and Their Pd (II) Complexes. Lddd. 2019, 16, 522–532. DOI: https://doi.org/10.2174/1570180815666180816124102.
- Frei, P.; Silbermann, M.; Mã¼Hlethaler, T.; Jiang, X.; Schwardt, O.; Hevey, R.; Ernst, B. Comparison of Affinity Ranking by Target-Directed Dynamic Combinatorial Chemistry and Surface Plasmon Resonance. Arkivoc 2019, 2019, 143–167. DOI: https://doi.org/10.24820/ark.5550190.p010.913.
- Tok, F.; Kocyigit-Kaymakcioglu, B.; Tabanca, N.; Estep, A. S.; Gross, A. D.; Geldenhuys, W. J.; Becnel, J. J.; Bloomquist, J. R. Synthesis and Structure-Activity Relationships of Carbohydrazides and 1,3,4-Oxadiazole Derivatives Bearing an Imidazolidine Moiety Against the Yellow Fever and Dengue Vector, Aedes Aegypti. Pest. Manag. Sci. 2018, 74, 413–421. DOI: https://doi.org/10.1002/ps.4722.
- Tok, F.; Uğraş, Z.; Sağlık, B. N.; Özkay, Y.; Kaplancıklı, Z. A.; Koçyiğit-Kaymakçıoğlu, B. Novel 2,5-Disubstituted-1,3,4-Oxadiazole Derivatives as MAO-B Inhibitors: Synthesis, Biological Evaluation and Molecular Modeling Studies. Bioorg. Chem. 2021, 112, 104917–104910. DOI: https://doi.org/10.1016/j.bioorg.2021.104917.
- Clinical and Laboratory Standard Institute (CLSI) 2007 Performance standards for antimicrobial susceptibility testing; 17th informational supplement. CLSI document MS100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
- Reller, L. B.; Weinstein, M.; Jorgensen, J. H.; Ferraro, M. J. Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices. Clin. Infect. Dis. 2009, 49, 1749–1755. DOI: https://doi.org/10.1086/647952.